224 related articles for article (PubMed ID: 11806849)
1. Surfactant gene polymorphisms and interstitial lung diseases.
Pantelidis P; Veeraraghavan S; du Bois RM
Respir Res; 2002; 3(1):14. PubMed ID: 11806849
[TBL] [Abstract][Full Text] [Related]
2. NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome".
Guillot L; Carré A; Szinnai G; Castanet M; Tron E; Jaubert F; Broutin I; Counil F; Feldmann D; Clement A; Polak M; Epaud R
Hum Mutat; 2010 Feb; 31(2):E1146-62. PubMed ID: 20020530
[TBL] [Abstract][Full Text] [Related]
3. A dominant negative variant of
Huang H; Pan J; Spielberg DR; Hanchard NA; Scott DA; Burrage LC; Dai H; Murdock D; Rosenfeld JA; Mohammad A; Huang T; Lindsey AG; Kim H; Chen J; Ramu A; Morrison SA; Dawson ZD; Hu AZ; Tycksen E; Silverman GA; Baldridge D; Wambach JA; ; Pak SC; Brody SL; Schedl T
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121658
[TBL] [Abstract][Full Text] [Related]
4. The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
Zarbock R; Woischnik M; Sparr C; Thurm T; Kern S; Kaltenborn E; Hector A; Hartl D; Liebisch G; Schmitz G; Griese M
BMC Pulm Med; 2012 Mar; 12():15. PubMed ID: 22458263
[TBL] [Abstract][Full Text] [Related]
5. [Interstitial lung disease in infants caused by genetic abnormalities].
Zheng Y; Chen H
Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):260-3. PubMed ID: 24915911
[No Abstract] [Full Text] [Related]
6. Surfactant protein deficiency in familial interstitial lung disease.
Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.
Citti A; Peca D; Petrini S; Cutrera R; Biban P; Haass C; Boldrini R; Danhaive O
Ultrastruct Pathol; 2013 Oct; 37(5):356-65. PubMed ID: 24047351
[TBL] [Abstract][Full Text] [Related]
8. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene.
Hamvas A; Nogee LM; White FV; Schuler P; Hackett BP; Huddleston CB; Mendeloff EN; Hsu FF; Wert SE; Gonzales LW; Beers MF; Ballard PL
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):771-6. PubMed ID: 14656744
[TBL] [Abstract][Full Text] [Related]
9. Surfactant lipidomics in healthy children and childhood interstitial lung disease.
Griese M; Kirmeier HG; Liebisch G; Rauch D; Stückler F; Schmitz G; Zarbock R;
PLoS One; 2015; 10(2):e0117985. PubMed ID: 25692779
[TBL] [Abstract][Full Text] [Related]
10. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
11. Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate.
Gupta A; Zheng SL
Arch Dis Child; 2017 Jan; 102(1):84-90. PubMed ID: 27417306
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.
Sumita Y; Sugiura T; Kawaguchi Y; Baba S; Soejima M; Murakawa Y; Hara M; Kamatani N
Rheumatology (Oxford); 2008 Mar; 47(3):289-91. PubMed ID: 18263595
[TBL] [Abstract][Full Text] [Related]
13. The surfactant system protects both fetus and newborn.
Hallman M
Neonatology; 2013; 103(4):320-6. PubMed ID: 23736009
[TBL] [Abstract][Full Text] [Related]
14. Genetic causes and clinical management of pediatric interstitial lung diseases.
Nathan N; Borensztajn K; Clement A
Curr Opin Pulm Med; 2018 May; 24(3):253-259. PubMed ID: 29517585
[TBL] [Abstract][Full Text] [Related]
15. Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults.
Borie R; Kannengiesser C; Dupin C; Debray MP; Cazes A; Crestani B
Presse Med; 2020 Jun; 49(2):104024. PubMed ID: 32437840
[TBL] [Abstract][Full Text] [Related]
16. Lung surfactant in subacute pulmonary disease.
Devendra G; Spragg RG
Respir Res; 2002; 3(1):19. PubMed ID: 11980588
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias.
Markart P; Ruppert C; Wygrecka M; Schmidt R; Korfei M; Harbach H; Theruvath I; Pison U; Seeger W; Guenther A; Witt H
Eur Respir J; 2007 Jan; 29(1):134-7. PubMed ID: 17005585
[TBL] [Abstract][Full Text] [Related]
18. A common mutation in the surfactant protein C gene associated with lung disease.
Cameron HS; Somaschini M; Carrera P; Hamvas A; Whitsett JA; Wert SE; Deutsch G; Nogee LM
J Pediatr; 2005 Mar; 146(3):370-5. PubMed ID: 15756222
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene.
Stevens PA; Pettenazzo A; Brasch F; Mulugeta S; Baritussio A; Ochs M; Morrison L; Russo SJ; Beers MF
Pediatr Res; 2005 Jan; 57(1):89-98. PubMed ID: 15557112
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Missense Mutation in the
Liu L; Liu YJ; Guo T; Luo H
DNA Cell Biol; 2021 Jan; 40(1):126-131. PubMed ID: 33181027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
